Literature DB >> 16935562

The Mirasol PRT system for pathogen reduction of platelets and plasma: an overview of current status and future trends.

Raymond P Goodrich1, Richard A Edrich, Junzhi Li, Jerard Seghatchian.   

Abstract

The safety of blood transfusion is still threatened by contamination of blood products with a variety of pathogens such as viruses, bacteria and parasites. A novel pathogen reduction process for platelets and plasma products, the Mirasol PRT system, has been developed and is under clinical evaluation for its efficacy and safety. The Mirasol PRT process is based on riboflavin photochemistry. This manuscript reviews current progress and future trends.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16935562     DOI： 10.1016/j.transci.2006.01.007

Source DB:  PubMed          Journal:  Transfus Apher Sci        ISSN： 1473-0502            Impact factor:   1.764


  31 in total

1.  Laboratory Evaluation of the Effectiveness of Pathogen Reduction Procedures for Bacteria.

Authors:  Thomas H Müller; Thomas Montag; Axel W Seltsam
Journal:  Transfus Med Hemother       Date:  2011-07-08       Impact factor: 3.747

Review 2.  Transfusion medicine and proteomics. Alliance or coexistence?

Authors:  Thomas Thiele; Leif Steil; Uwe Völker; Andreas Greinacher
Journal:  Blood Transfus       Date:  2010-06       Impact factor: 3.443

Review 3.  Emerging Pathogens - How Safe is Blood?

Authors:  Michael Schmidt; Wolf-Jochen Geilenkeuser; Walid Sireis; Erhard Seifried; Kai Hourfar
Journal:  Transfus Med Hemother       Date:  2013-12-27       Impact factor: 3.747

4.  UVC Irradiation for Pathogen Reduction of Platelet Concentrates and Plasma.

Authors:  Axel Seltsam; Thomas H Müller
Journal:  Transfus Med Hemother       Date:  2011-01-22       Impact factor: 3.747

5.  In vitro evaluation of pathogen-inactivated buffy coat-derived platelet concentrates during storage: psoralen-based photochemical treatment step-by-step.

Authors:  Mélanie Abonnenc; Giona Sonego; Julie Kaiser-Guignard; David Crettaz; Michel Prudent; Jean-Daniel Tissot; Niels Lion
Journal:  Blood Transfus       Date:  2014-10-23       Impact factor: 3.443

6.  The Mirasol Pathogen Reduction Technology system and quality of platelets stored in platelet additive solution.

Authors:  Håkon Reikvam; Susanne Marschner; Torunn Oveland Apelseth; Ray Goodrich; Tor Hervig
Journal:  Blood Transfus       Date:  2010-07       Impact factor: 3.443

Review 7.  Pathogen-reduced platelets for the prevention of bleeding.

Authors:  Lise J Estcourt; Reem Malouf; Sally Hopewell; Marialena Trivella; Carolyn Doree; Simon J Stanworth; Michael F Murphy
Journal:  Cochrane Database Syst Rev       Date:  2017-07-30

Review 8.  Health Technology Assessment of pathogen reduction technologies applied to plasma for clinical use.

Authors:  Americo Cicchetti; Alexandra Berrino; Marina Casini; Paola Codella; Giuseppina Facco; Alessandra Fiore; Giuseppe Marano; Marco Marchetti; Emanuela Midolo; Roberta Minacori; Pietro Refolo; Federica Romano; Matteo Ruggeri; Dario Sacchini; Antonio G Spagnolo; Irene Urbina; Stefania Vaglio; Giuliano Grazzini; Giancarlo M Liumbruno
Journal:  Blood Transfus       Date:  2016-07       Impact factor: 3.443

9.  The influence of riboflavin photochemistry on plasma coagulation factors.

Authors:  Luis Larrea; María Calabuig; Vanesa Roldán; José Rivera; Han-Mou Tsai; Vicente Vicente; Roberto Roig
Journal:  Transfus Apher Sci       Date:  2009-09-25       Impact factor: 1.764

10.  Evaluation of antibacterial efficacy of photo-activated riboflavin using ultraviolet light (UVA).

Authors:  Karim Makdoumi; Anders Bäckman; Jes Mortensen; Sven Crafoord
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-11-18       Impact factor: 3.117
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.